Cargando…
P450: ALDH1A AS A THERAPEUTIC TARGET IN ACUTE MYELOID LEUKEMIA
Autores principales: | Shaikh, Mehak, Yazir, Muhube, Baier, Céline, Constantineascu, Andrada, Vackova, Julie, Adamcova, Miroslava K., Perez-Alea, Mileidys, Alberich-Jorda, Meritxell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429494/ http://dx.doi.org/10.1097/01.HS9.0000968708.47762.a9 |
Ejemplares similares
-
Response to NK cell content does not seem to influence engraftment in ex vivo T cell depleted haploidentical stem cell transplantation
por: Lobo de Figueiredo-Pontes, Lorena, et al.
Publicado: (2022) -
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia
por: Hartmann, Jens-Uwe, et al.
Publicado: (2018) -
Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway
por: Grusanovic, Srdjan, et al.
Publicado: (2022) -
S253: IMPAIRED HSC FITNESS AND ACCELERATED LEUKEMOGENESIS IN A MOUSE MODEL OF CHRONIC INFLAMMATION
por: Grusanovic, Srdjan, et al.
Publicado: (2023) -
The rarity of ALDH
(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
por: Hoang, Van T., et al.
Publicado: (2015)